Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cytarabine (cytosar-u) (1 trial)
naltrexone (revia) (1 trial)
Lymphoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)